The 503A compounding timeline September 2023 FDA placed ipamorelin (and several other peptides) on Category 2 of the interim 503A bulks list
In general, when people think about hormone therapies, they're thinking testosterone, estrogen, pregnanolone, thyroid, et cetera
Leptin Sensitivity : Emerging research suggests it may improve leptin signaling, helping the body better recognize satiety cues
It's there to let your body adjust before moving to therapeutic doses
At Florida Endocrinology and Diabetes Center , we prescribe GLP-1 medications thoughtfully and strategically, focusing on patient safety, long-term metabolic health, and realistic expectations
Pereira says that medication shortages impacted her patients, who had to switch to less effective drugs, which is especially concerning for patients with diabetes who need the medications to keep their blood glucose in a safe range